Forward Pharma A/S reported condensed consolidated earnings results for the fourth quarter and year ended December 31, 2017. For the year, the company reported net income before taxes of $1,187,397,000 against net loss of $54,539,000 a year ago. Net income was $917,093,000 or $2.30 per share basic and diluted against net loss of $33,336,000 or $0.06 per share basic and diluted a year ago. Total operating income of $1,187,397,000 compared to loss of $55,434,000 a year ago.